IDYA
IDYA
NASDAQ · Biotechnology

Ideaya Biosciences Inc

$28.32
+0.08 (+0.28%)
As of May 9, 1:26 AM ET ·
Financial Highlights (FY 2026)
Revenue
216.55M
Net Income
-112,573,591
Gross Margin
Profit Margin
-52.0%
Rev Growth
+62.5%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.1% 60.1%
Operating Margin -72.8% -65.6% -18.9% -18.0%
Profit Margin -52.0% -49.4% -21.1% -18.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 216.55M 133.23M 384.15M 440.58M
Gross Profit 230.71M 264.60M
Operating Income -157,736,749 -87,340,392 -72,666,854 -79,390,880
Net Income -112,573,591 -62,333,106 -80,984,777 -83,452,264
Gross Margin 60.1% 60.1%
Operating Margin -72.8% -65.6% -18.9% -18.0%
Profit Margin -52.0% -49.4% -21.1% -18.9%
Rev Growth +62.5% +62.5% -7.8% +21.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 452.34M 383.43M
Total Equity 2.04B 2.12B
D/E Ratio 0.22 0.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -155,065,763 -90,631,521 -85,173,040 -109,288,960
Free Cash Flow -100,075,430 -111,173,636